Cardinal Health 2030 remained flat by 0.0% to $306.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.9%, from $249.00M to $306.00M. This is a positive signal — lower values indicate better performance for this metric.
Provides insight into the long-term impact of past acquisitions on future earnings quality.
The projected amortization expense for finite-lived intangible assets specifically for the fiscal year 2030. This metric...
Standard multi-year amortization schedule disclosure.
other_finite_lived_intangible_assets_amortization_expens_4a0a03| Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $212.00M | $210.00M | $208.00M | $174.00M | $176.00M | $177.00M | $146.00M | $148.00M | $186.00M | $186.00M | $208.00M | $249.00M | $284.00M | $306.00M | $306.00M |
| QoQ Change | — | -0.9% | -1.0% | -16.3% | +1.1% | +0.6% | -17.5% | +1.4% | +25.7% | +0.0% | +11.8% | +19.7% | +14.1% | +7.7% | +0.0% |
| YoY Change | — | — | — | -17.9% | -16.2% | -14.9% | -16.1% | -15.9% | +5.1% | +27.4% | +40.5% | +33.9% | +52.7% | +47.1% | +22.9% |